Specialty Pharmacy

Dried plums may support retention of beneficial microbiota and patterns of microbial metabolism.

New approach may stop growth and kill cancer cells.

Excessive out-of-pocket costs can become an adverse event from treatment.

The FDA is considering approval for Sanofi's lixisenatide type 2 diabetes treatment.

Luteolin may carry significant anti-tumor effects.

Lengthening time between treatment with anti-TNF agents may improve adherence.

Sleep-wake cycle may link to exacerbated MS symptoms.

Velpatasvir is a pangenotypic NS5A inhibitor for patients with hepatitis C genotypes 1 through 6 of the virus.

Ocrelizumab found to decrease progression of clinical disability.

Patients treated with atezolizumab lived an average of 7.7 months longer than people treated with docetaxel chemotherapy.

MECP2 duplication syndrome is caused by duplication of genetic material in a specific region of the X chromosome.

Medical marijuana shows favorable safety profile.

Desmoplasmic melanoma possesses a mutation that protects tumors from destruction by the immune system.

The treatment mantra for human immunodeficiency virus (HIV) is almost-perfect lifelong adherence to antiretroviral therapy (ART).

Independent pharmacies will want to consider updating their credit card processing terminals to accept EMV chip cards this fall.

Experimental drug blocks key sites on the virus surface that attach and invade human immune cells.

Shoulder muscle strength found to decrease even in early stage RA patients.

Top news of the week in oncology drug development.

Discovery could lead to treatments that stop cancer recurrence.

For patients with hepatitis C seeking modern treatment options, many health plans force health care professionals use criteria that are clinically unsound.

More than just biological factors can affect patient outcomes.

Top stories of the week on Specialty Pharmacy Times.

Self-testing may help control global spread of HIV/AIDS.

Mild psoriasis, severe psoriasis, and psoriatic arthritis may also bring increased comorbidities.

Expansion covers patients who have greater than 30% myeloblasts.

Average time for withdrawals in colonoscopies came in at approximately 8.6 minutes.

Intralesional interleukin-2 shows promise in cutaneous melanoma metastases.

Childhood pneumonia carries a higher risk of chronic bronchitis and other disease-related quality of life issues.